Literature DB >> 20367358

Fusiform dilation of the carotid artery following radical resection of pediatric craniopharyngiomas: natural history and management.

Robert E Elliott1, Jeffrey H Wisoff.   

Abstract

OBJECT: Fusiform dilation of the supraclinoid internal carotid artery (FDCA) is a reported occurrence following surgery for suprasellar tumors, in particular craniopharyngiomas. We report our experience of the incidence and natural history of FDCA following aggressive surgical resection of craniopharyngiomas in children.
METHODS: Between 1986 and 2006, 86 patients under the age of 21 underwent radical resection of craniopharyngiomas at our institution. Ten cases with < 1 year of follow-up imaging (6), perioperative death (3), or nonsuprasellar tumors (1) were excluded. Data were retrospectively collected on the remaining 76 patients (43 male, 33 female; mean age 9.5 years; mean tumor size 3.3 cm) to determine the risk factors for and the rate and clinical significance of FDCA.
RESULTS: Fifty patients had primary tumors and 26 patients received treatment before referral to our center. Sixty-six children (87%) had gross-total resection. At a mean follow-up time of 9.9 years, FDCA had developed in 7 patients (9.2%), all of whom had primary tumors and gross-total resection. The mean time to onset of FDCA was 6.8 months (range 3-11 months) with stabilization occurring at mean of 17.7 months (range 9-29.5 months). The mean size of the aneurysms was 9.1 mm (range 7.1-12 mm). After arrest, no lesions showed continued growth on serial imaging or produced symptoms or required treatment. There were no significant differences in age, sex, tumor size, pre- or retrochiasmatic location, extent of resection, or surgical approach (p > 0.05) between patients with and without FDCA.
CONCLUSIONS: Fusiform dilation of the supraclinoid internal carotid artery occurred in almost 10% of children following radical resection of craniopharyngiomas. In agreement with other reports, the authors concluded that FDCA probably occurs as a result of surgical manipulation of the supraclinoid carotid artery and should be managed conservatively because very few patients exhibit continued symptoms or experience growth or rupture of the lesion.

Entities:  

Mesh:

Year:  2010        PMID: 20367358     DOI: 10.3171/2010.1.FOCUS09296

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  6 in total

Review 1.  Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.

Authors:  Christopher Salvatore Graffeo; Avital Perry; Michael J Link; David J Daniels
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

2.  The eagle sign: a new preoperative MRI-based tool for predicting topographic correlation between craniopharyngioma and hypothalamus.

Authors:  ShaoYang Li; Le Yang; ZhiGao Tong; BoWen Wu; Bin Tang; ShenHao Xie; MinDe Li; Lin Zhou; ChenXing Ouyang; Xiao Wu; YouQing Yang; ChunLiang Wang; Tao Hong
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-09       Impact factor: 4.322

3.  Fusiform dilatation of the internal carotid artery in childhood-onset craniopharyngioma: multicenter study on incidence and long-term outcome.

Authors:  Anika Hoffmann; Monika Warmuth-Metz; Kristin Lohle; Julia Reichel; Anna M M Daubenbüchel; Anthe S Sterkenburg; Hermann L Müller
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

4.  Unique Case of Spontaneous Basilar Artery Stroke in an Operated Child with Craniopharyngioma.

Authors:  Krishna Shah; Shrey Jain; Ajit K Sinha
Journal:  Asian J Neurosurg       Date:  2022-08-25

5.  Pituitary stalk management during the microsurgery of craniopharyngiomas.

Authors:  Gelei Xiao; Xianrui Yuan; Jian Yuan; Nadeem Akhtar Krumtally; Yifeng Li; Chengyuan Feng; Qing Liu; Zefeng Peng; Xuejun Li; Xiping Ding
Journal:  Exp Ther Med       Date:  2014-02-19       Impact factor: 2.447

6.  Cerebral Infarction in Childhood-Onset Craniopharyngioma Patients: Results of KRANIOPHARYNGEOM 2007.

Authors:  Svenja Boekhoff; Brigitte Bison; Daniela Genzel; Maria Eveslage; Anna Otte; Carsten Friedrich; Jörg Flitsch; Hermann L Müller
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.